MERZ AESTHETICS ANNOUNCES THREE YEAR FDA CLEARANCE FOR CELLFINA® SYSTEM
RALEIGH, N.C. – OCTOBER 17, 2016 – Merz Aesthetics, a division of Merz North America (U.S. affiliate of the global Merz Pharma Group), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Cellfina® System for the long-term improvement in the appearance of cellulite on the buttocks and thighs of adult females with no loss of benefit for up to 3 years.
MERZ ANNOUNCES CE CLEARANCE OF THE CELLFINA® SYSTEM FOR THE LONG-TERM REDUCTION OF CELLULITE
FRANKFURT, GERMANY – JULY 14, 2016 – Merz Pharma Group today announced CE Mark clearance of the Cellfina® System, signifying its conformity with all EU regulations. Cellfina® is intended for long-term reduction of cellulite in the buttocks and thighs by precise release of targeted structural tissue (fibrous septae). Results of treatment with Cellfina® are expected to last up to two years. Cellfina® is currently available in the U.S. and has the longest duration of results as cleared by the U.S. Food and Drug Administration (FDA).
Welcome to the Global Cellfina site. This message is to notify you that you have been redirected from another Merz site. The information you are being referred to may not comply with regulatory requirements. Further information is available from Merz or via the local instructions for use or product information.